Lapatinib and chronic renal insufficiency

Lapatinib is an intracellular tyrosine-kinase inhibitor of both EGFR (ErbB1) and HER2 (ErbB2) receptors, which is indicated in the treatment of metastatic disease pretreated with anti-HER2 therapies. We report the clinical case of a woman with chronic renal failure in dialysis affected by HER2-posi...

Full description

Bibliographic Details
Main Author:	Luca Moscetti
Format:	Article
Language:	English
Published:	AboutScience Srl 2018-03-01
Series:	AboutOpen
Subjects:	Lapatinib breast cancer metastatic breast cancer HER2
Online Access:	https://journals.aboutscience.eu/index.php/aboutopen/article/view/6

id	doaj-ccf6fcec401f4fe3bfca3f1820bd12cc
record_format	Article
spelling	doaj-ccf6fcec401f4fe3bfca3f1820bd12cc2020-11-25T03:19:28ZengAboutScience SrlAboutOpen2465-26282018-03-014110.19156/abtpn.2018.0031Lapatinib and chronic renal insufficiencyLuca Moscetti0Dipartimento di Oncologia-Ematologia, Azienda Ospedaliero-Universitaria di Modena, Modena (Italy) Lapatinib is an intracellular tyrosine-kinase inhibitor of both EGFR (ErbB1) and HER2 (ErbB2) receptors, which is indicated in the treatment of metastatic disease pretreated with anti-HER2 therapies. We report the clinical case of a woman with chronic renal failure in dialysis affected by HER2-positive metastatic breast neoplasia and treated with lapatinib and letrozole (Oncology). https://journals.aboutscience.eu/index.php/aboutopen/article/view/6Lapatinibbreast cancermetastatic breast cancerHER2
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Luca Moscetti
spellingShingle	Luca Moscetti Lapatinib and chronic renal insufficiency AboutOpen Lapatinib breast cancer metastatic breast cancer HER2
author_facet	Luca Moscetti
author_sort	Luca Moscetti
title	Lapatinib and chronic renal insufficiency
title_short	Lapatinib and chronic renal insufficiency
title_full	Lapatinib and chronic renal insufficiency
title_fullStr	Lapatinib and chronic renal insufficiency
title_full_unstemmed	Lapatinib and chronic renal insufficiency
title_sort	lapatinib and chronic renal insufficiency
publisher	AboutScience Srl
series	AboutOpen
issn	2465-2628
publishDate	2018-03-01
description	Lapatinib is an intracellular tyrosine-kinase inhibitor of both EGFR (ErbB1) and HER2 (ErbB2) receptors, which is indicated in the treatment of metastatic disease pretreated with anti-HER2 therapies. We report the clinical case of a woman with chronic renal failure in dialysis affected by HER2-positive metastatic breast neoplasia and treated with lapatinib and letrozole (Oncology).
topic	Lapatinib breast cancer metastatic breast cancer HER2
url	https://journals.aboutscience.eu/index.php/aboutopen/article/view/6
work_keys_str_mv	AT lucamoscetti lapatinibandchronicrenalinsufficiency
_version_	1724622141077323776

Lapatinib and chronic renal insufficiency

Similar Items